Meritech Capital Partners is a concentrated late-stage technology investor focused on backing category-leading companies in the technology markets it believes matter most. The firm underwrites heavily to durable growth quality, strong unit economics, and public-market readiness, typically investing from Series B through pre-IPO as a hands-on board partner.
Meritech invests when a company demonstrates clear category leadership or a credible path to it, coupled with high‑quality growth metrics: strong net‑dollar retention, robust sales efficiency (payback and magic number), healthy gross margins, and an improving free‑cash‑flow profile that enables a favorable Rule‑of‑40. The firm also looks for public‑market readiness within a reasonable horizon, as it prefers to add value as a board partner through the exit. Red flags include “growth at all costs” without efficiency, weak NDR, excessive burn, and lack of deep customer adoption. While the process is heavily metrics‑driven, Meritech weighs team execution as essential to sustaining leadership; however, market position and traction tend to dominate the decision matrix. Recent deals such as Huntress (Series D), fal (Series C), inforcer (Series A), Icertis (Series D) and 10x Genomics (Series D) illustrate a pattern of leading large late‑stage rounds, performing extensive customer diligence, and anchoring rounds with sizable checks.
See the rest of how Meritech Capital Partners decides.
Evaluation framework, investment themes, pitch guidance and the partner map. One email, no password — we send a link and you land right back here.